Patient Pathfinder: Clinical Trials
Clinical Trials for Von Hippel-Lindau Disease
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 11 active Von Hippel-Lindau Disease trials
Data Collection Protocol for Patients With Von Hippel Lindau Disease
Study Type: Observational
National Eye Institute Biorepository for Retinal Diseases
Study Type: Observational
Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
Study Type: Observational
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Study Type: Interventional Phase 2
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Study Type: Observational
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Study Type: Interventional Phase 2
Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma
Study Type: Observational
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Study Type: Interventional Phase 1
There are 11 active Von Hippel-Lindau Disease trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now